Join the club for FREE to access the whole archive and other member benefits.

SENISCA to reverse senescence by targeting RNA splicing patterns

08-Apr-2022

Key points from article :

SENISCA’s Co-founder Lorna Harries talks oligos, splicing and skin aging at the fourth annual Longevity Leaders World Congress.

- Rejuvenating senescent cells, rather than clearing them, but it depends on the end goal.

- In cell poor tissues or sites, you need to preserve tissue integrity, a senomorphic approach might be better.

- We can rejuvenate and attenuate the SASP without inducing the cells to divide, because they may have features of ageing.

- Evidence for dysregulation of splicing to be classified as a hallmark of ageing.

- Small molecules or oligonucleotides to block interactions at genes and processes that affect signalling pathways.

- More advantages if the target genes are known.

- Oligos can be used at very low doses, with exquisite specificity; off target effects are much rarer.

- Conjugate oligos to targeting proteins, or targeted nanoparticles which can deliver directly to the cells of interest.

- Can used oligos systemically or locally with little or no distribution to other organs.

Lorna Harries details significant breakthroughs at fourth annual Longevity Leaders World Congress

Mentioned in this article:

Tap on icon for description, click on resource name for more details.

Academic

Professor of Molecular Genetics at the University of Exeter.

Company

University of Exeter spinout aiming to develop senotherapeutic interventions